Yale Cancer Center
A

Microenvironmental Determinants of Systemic Therapy Response in Kidney Cancer: From Human to Mouse and Back

By Yale Cancer Center FEATURING Ari Hakimi
By Yale Cancer Center FEATURING Ari Hakimi
15 views
April 18, 2024
Comments 0
Login to view comments. Click here to Login

Featured Video

20:14
Exelixis

Hypothetical Patient Case: RAI-R Metastatic Differentiated Thyroid C…

Feat. R. Alter, R. Shameem

Featured Video

17:48
Exelixis

Hypothetical Patient Case: 1L Advanced Renal Cell Carcinoma With Mul…

Feat. R. Alter, A. Rezazadeh

Recommended

RENALC-BLADDR-PROSCA 2024

RENALC 2024 - Hybrid Global Forum on GU Oncology

Tue, Nov 26, 2024
16:05

Recent GU Developments and Their Clinical Implications

Insights from 2024 ASCO® GU Annual Meeting

T. Powles, B. Rini

1.5K views
17:50

Clinical Highlights From AACR 2024: Trials Evaluating Selected New T…

AdventHealth

G. Sonpavde

1.9K views
29:25

Hyperprogression in Cancer Treated With Immunotherapy

Northwestern Medicine Oncology and Hematology

Y. Chae

1.2K views
23:17

Clinical Applications of ctDNA in Breast Cancer Diagnosis and Manage…

University of Miami Sylvester Comprehensive Cancer Center

D. Tripathy

619 views
13:37

SIR 2023: Renal Cell Carcinoma Guidelines - What's New in 2023?

SIR 2023 Conference Coverage

N. Kothary

3.0K views
15:58

Best of Bladder Cancer and RCC From ESMO 2023 and GU ASCO 2024

Total Health

M. Reimers

529 views
10:19

ASCO® 2024 Summary: "Current Updates in RCC - Clinical Implications …

2024 ASCO® Annual Meeting Insights Hub

K. Mittal

365 views
16:57

ASCO® 2024 Precision Medicine Highlights: LAURA and CROWN Trials (NS…

2024 ASCO® Annual Meeting Insights Hub

V. Subbiah

678 views
15:22

ESMO 2024 Summary: The Emerging Global Epidemic of Early-Onset Cance…

2024 ESMO Annual Meeting Insights Hub

S. Ogino

262 views
45:56

Endocrine Adverse Events From Checkpoint Inhibitors

Yale Cancer Center

K. Herold

867 views
07:27

Opus One: Final Results - RFA in Axial Skeleton

Jason Levy

2.0K views
16:25

New

Visible vs. Invisible Cancers - The Genomics and Natural History

Laurence Klotz

179 views
06:47

Tumor-Agnostic Efficacy & Safety of Selpercatinib in RET Fusion+ Sol…

UCSF School of Medicine

H. Kang

2.1K views
55:10

History of Cancer and Its Treatment: What Will It Take to Cure?

University of Colorado Cancer Center

C. Lieu

323 views
20:07

New

ESMO 2024 Summary: Developmental Therapeutics Highlights

2024 ESMO Annual Meeting Insights Hub

G. Sonpavde

238 views
15:28

ASCO® 2024 Summary: "Bladder and RCC Highlights"

2024 ASCO® Annual Meeting Insights Hub

K. Tawagi, N. Reizine

263 views
19:00

New

Treatment (De)Intensification in RCC

International Urology Cancer Summit - IUCS

S. Kumar Pal

155 views
06:41

No Role to Continue ICI Beyond Progression: CONTACT-03 & TiNivo-2 Ph…

Dana-Farber Cancer Institute

B. McGregor

135 views
06:57

ASCO® 2023 Insights: "ESR1 Mutational Landscape and Impact of Co-Exi…

Insights from 2023 ASCO® Annual Meeting

A. Medford

830 views
22:36

Understanding CRISPR and Gene Editing in the Treatment of Heme Malig…

UChicago Medicine

A. Cooper

243 views
AUTOPLAY